Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11974969 | 0.92 | SLC22A12 (0.54) | SLC22A12HDAC8 | |
| SCHEMBL11977334 | 0.92 | SLC22A12 (0.66) | SLC22A12HDAC8 | |
| SCHEMBL11976836 | 0.86 | SLC22A12 (0.66) | SLC22A12HDAC8 | |
| SCHEMBL11974953 | 0.84 | SLC22A12 (0.48) | SLC22A12HDAC8 | |
| SCHEMBL11975788 | 0.81 | SLC22A12 (0.43) | SLC22A12HDAC8 | |
| SCHEMBL11976835 | 0.81 | SLC22A12 (0.54) | SLC22A12HDAC8 | |
| SCHEMBL11977339 | 0.81 | SLC22A12 (0.46) | SLC22A12HDAC8 | |
| SCHEMBL11974999 | 0.80 | SLC22A12 (0.58) | SLC22A12 | |
| SCHEMBL11976527 | 0.80 | SLC22A12 (0.62) | SLC22A12HDAC8 | |
| SCHEMBL11977062 | 0.79 | HDAC8 (0.49) | SLC22A12HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9359350-B2 | Ring-fused compound | SATO PHARMACEUTICAL CO., LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20150203490-A1 | RING-FUSED COMPOUND | SATO PHARMACEUTICAL CO., LTD. (JP) | 2015-07-23 | — | — | US | disclosed |
| US-8987473-B2 | Ring-fused compound | SATO PHARMACEUTICAL CO., LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203490-A1 | RING-FUSED COMPOUND | URB2, RCOR1, RCC2 | SLC22A12 394/4885HDAC8 2042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.